-
公开(公告)号:CA2729217A1
公开(公告)日:2009-12-30
申请号:CA2729217
申请日:2009-06-24
Applicant: ARRAY BIOPHARMA INC
Inventor: BURGESS LAURENCE E , CLARK CHRISTOPHER T , COOK ADAM , CORRETTE CHRISTOPHER P , DELISLE ROBERT KIRK , DOHERTY GEORGE A , HUNT KEVIN W , ROMOFF TODD , KIM GANGHYEOK
IPC: C07D311/04 , A61K31/353 , A61P29/00 , C07D405/12 , C07D407/12
Abstract: Compounds of Formula (I): in which A1, A2, W, L, G, R7a, R7b, R8, R9 and R10 have the meanings given in the specification, are DP2 receptor modulators useful in the treatment of immunologic diseases.
-
公开(公告)号:MY161425A
公开(公告)日:2017-04-14
申请号:MYPI2010006174
申请日:2009-06-24
Applicant: ARRAY BIOPHARMA INC
Inventor: BURGESS LAURENCE E , CLARK CHRISTOPHER T , COOK ADAM , CORRETTE CHRISTOPHER P , DELISLE ROBERT KIRK , DOHERTY GEORGE A , HUNT KEVIN W , ROMOFF TODD , KIM GANGHYEOK
IPC: C07D311/04 , A61K31/353 , A61P29/00 , C07D405/12 , C07D407/12
Abstract: COMPOUNDS OF FORMULA (I): IN WHICH A1, A2, W, L, G, R7a, R7b, R8, R9 AND R10 HAVE THE MEANINGS GIVEN IN THE SPECIFICATION, ARE DP2 RECEPTOR MODULATORS USEFUL IN THE TREATMENT OF IMMUNOLOGIC DISEASES.
-
公开(公告)号:CA2748099C
公开(公告)日:2017-02-28
申请号:CA2748099
申请日:2009-12-18
Applicant: ARRAY BIOPHARMA INC
Inventor: COOK ADAM , HUNT KEVIN W , DELISLE ROBERT KIRK , ROMOFF TODD , CLARK CHRISTOPHER T , KIM GANGHYEOK , CORRETTE CHRISTOPHER P , DOHERTY GEORGE A , BURGESS LAURENCE E
IPC: C07D405/12 , A61K31/353 , A61P29/00 , C07D405/14 , C07D413/12 , C07D417/12
Abstract: Compounds of Formula I: (I) in which A, A', R1, R7a, R7b, R8 and R10 have the meanings given in the specification, are DP2 receptor inhibitors useful in the treatment of useful in the treatment and prevention of immunologic diseases, allergic diseases such as asthma, allergic rhinitis and atopic dermatitis, and other inflammatory diseases mediated by prostaglandin D2 (PGD2). The compounds of Formula I may also be useful in treating diseases or medical conditions involving the Th2 T cell via production of IL-4, IL-5 and/or IL-13.
-
公开(公告)号:HRP20140988T1
公开(公告)日:2014-12-05
申请号:HRP20140988
申请日:2014-10-15
Applicant: ARRAY BIOPHARMA INC
Inventor: BURGESS LAURENCE E , CLARK CHRISTOPHER T , COOK ADAM , CORRETTE CHRISTOPHER P , DELISLE ROBERT KIRK , DOHERTY GEORGE A , HUNT KEVIN W , ROMOFF TODD , KIM GANGHYEOK
IPC: C07D311/04 , A61K31/353 , A61P29/00 , C07D405/12 , C07D407/12
-
公开(公告)号:ES2524314T3
公开(公告)日:2014-12-05
申请号:ES09770959
申请日:2009-06-24
Applicant: ARRAY BIOPHARMA INC
Inventor: BURGESS LAURENCE , CLARK CHRISTOPHER , COOK ADAM , CORRETTE CHRISTOPHER , DELISLE ROBERT , DOHERTY GEORGE , HUNT KEVIN , ROMOFF TODD , KIM GANGHYEOK
IPC: C07D311/04 , A61K31/353 , A61P29/00 , C07D405/12 , C07D407/12
Abstract: Compuesto de fórmula general I:**Fórmula** o una sal del mismo, en la que: A1 es hidrógeno, CN, Cl, F, Br, OMe, (alquilo de C1-4) o ciclopropilo; A2 es hidrógeno, Cl, Br, F, (alquilo de C1-4) o ciclopropilo; W es -C(>=O)NR1- o -NR2C(>=O)-; R1 y R2 son cada uno hidrógeno o metilo; L es un enlace, -(CR3R4)n-(CRaRb)m-(CR5R6)-*, alquenileno (C2-4), -O(alquilo de C1-4)-*, -(alquilo de C1-4)-O- *, -(alquilo de C1-4)-S-*,cicloalquileno (C3-6), o hetCyc1, en los que * indica el punto de unión a G, con la condición de que cuando W sea -NR2C(>=O)-;entonces L no sea - (CH>=CH)-; m >= 0, 1 o 2; n >= 0 o 1; Ra y Rb se seleccionan independientemente de hidrógeno y (alquilo de C1-4); R3 es hidrógeno, (alquilo de C1-4) o CH2OH; R4 es hidrógeno o metilo; R5 es hidrógeno, (alquilo de C1-4), OH, -O(alquilo de C1-4) o F; R6 es hidrógeno, F o metilo, o R5 y R6, junto con el carbono al que están unidos, forman un anillo de ciclopropilo, hetCyc1 es un grupo que presenta la fórmula en la que t es 1 o 2 y p es 0 o 1, y * indica el punto de unión a G; G es Ar1, Ar2, naftilo, un anillo de cicloalquilo (C5-6) benzocondensado opcionalmente sustituido con uno o más sustituyentes seleccionados independientemente de Cl y OMe, un anillo heterocíclico de 5-6 miembros benzocondensado que presenta 1-2 heteroátomos seleccionados independientemente de O y N, un anillo de cicloalquilo (C3-6) opcionalmente sustituido con uno o más sustituyentes seleccionados independientemente de alquilo (C1-4), un anillo de oxaespirononanilo, o t-butilo.
-
公开(公告)号:DK2307397T3
公开(公告)日:2014-11-03
申请号:DK09770959
申请日:2009-06-24
Applicant: ARRAY BIOPHARMA INC
Inventor: KIM GANGHYEOK , BURGESS LAURENCE E , CLARK CHRISTOPHER T , COOK ADAM , CORRETTE CHRISTOPHER P , DELISLE ROBERT KIRK , DOHERTY GEORGE A , HUNT KEVIN W , ROMOFF TODD
IPC: C07D311/04 , A61K31/353 , A61P29/00 , C07D405/12 , C07D407/12
-
公开(公告)号:NZ590437A
公开(公告)日:2012-07-27
申请号:NZ59043709
申请日:2009-06-24
Applicant: ARRAY BIOPHARMA INC
Inventor: BURGESS LAURENCE E , CLARK CHRISTOPHER T , COOK ADAM , CORRETTE CHRISTOPHER P , DELISLE ROBERT KIRK , DOHERTY GEORGE A , HUNT KEVIN W , ROMOFF TODD , GANGHYEOK KIM
IPC: A61K31/353 , A61P29/00 , C07D311/04 , C07D405/12 , C07D407/12
Abstract: Disclosed is a phenoxychroman carboxylic acid derivative of formula I, or a salt of the compound, wherein the substituents are as defined in the specification. These compounds are described as DP2 receptor antagonists. Also disclosed is the use of the compound for treating an immunologic disorder. Also disclosed is a method of synthesising the compound, and intermediates useful for that synthesis.
-
公开(公告)号:CL2010001528A1
公开(公告)日:2011-07-01
申请号:CL2010001528
申请日:2010-12-23
Applicant: ARRAY BIOPHARMA INC
Inventor: CLARK CHRISTOPHER T , COOK ADAM , DELISLE ROBERT KIRK , DOHERTY GEORGE A , HUNT KEVIN W , KIM GANGHYEOK , ROMOFF TODD , BURGESS LAURENCE E , CORRETTE CHRISTOPHER P
IPC: A61K31/353 , A61P29/00 , A61P37/00 , C07D207/335 , C07D311/04 , C07D405/12 , C07D407/12
Abstract: COMPUESTOS DE LA FÓRMULA I, E INTERMEDIARIOS DE FÓRMULA LE, VI Y IV, SEGÚN EN DONDE A1, A2, PG, W, L, G, R7A, R7B, R8, R9, R10, P3, P2 Y Z2 TIENEN LAS DEFINICIONES QUE SE DIERON EN LA MEMORIA DESCRIPTIVA, SON MODULADORES DE RECEPTOR DE DP2 QUE SON ÚTILES EN EL TRATAMIENTO DE ENFERMEDADES INMUNOLÓGICAS.
-
公开(公告)号:MX2011000173A
公开(公告)日:2011-06-20
申请号:MX2011000173
申请日:2009-06-24
Applicant: ARRAY BIOPHARMA INC
Inventor: KIM GANGHYEOK , BURGESS LAURENCE E , CLARK CHRISTOPHER T , COOK ADAM , CORRETTE CHRISTOPHER P , DELISLE ROBERT KIRK , DOHERTY GEORGE A , HUNT KEVIN W , ROMOFF TODD
IPC: A61K31/353 , C07D311/04 , A61P29/00 , C07D405/12 , C07D407/12
Abstract: Compuestos de la Fórmula 1 (ver fórmula (I)) en donde A1, A2, W, L, G, R7a, R7b, R8, R9 y R10 tienen las definiciones que se dieron en la memoria descriptiva, son moduladores de receptor de DP2 que son útiles en el tratamiento de enfermedades inmunológicas.
-
公开(公告)号:CA2748099A1
公开(公告)日:2010-07-01
申请号:CA2748099
申请日:2009-12-18
Applicant: ARRAY BIOPHARMA INC
Inventor: COOK ADAM , HUNT KEVIN W , DELISLE ROBERT KIRK , ROMOFF TODD , CLARK CHRISTOPHER T , KIM GANGHYEOK , CORRETTE CHRISTOPHER P , DOHERTY GEORGE A , BURGESS LAURENCE E
IPC: C07D405/12 , A61K31/353 , A61P29/00 , C07D405/14 , C07D413/12 , C07D417/12
Abstract: Compounds of Formula I: (I) in which A, A1, R1, R7a, R7b, R8 and R10 have the meanings given in the specification, are DP2 receptor inhibitors useful in the treatment of useful in the treatment and prevention of immunologic diseases, allergic diseases such as asthma, allergic rhinitis and atopic dermatitis, and other inflammatory diseases mediated by prostaglandin D2 (PGD2). The compounds of Formula I may also be useful in treating diseases or medical conditions involving the Th2 T cell via production of IL-4, IL-5 and/or IL-13.
-
-
-
-
-
-
-
-
-